Inventor · disambiguated record
Sandra Dunn
Also filed as: DUNN SANDRA · DUNN SANDRA E
7 granted patents·4 pending applications·21 citations·filing 2013–2022
81Inventor score
Top patents by PatentIndex Score
11 records- 0192US9771366B2Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitorsPHOENIX MOLECULAR DESIGNS·Filed 2017·Granted Sep 26, 2017·11 cites·20 claims
- 0286US10081632B2Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-α]pyrazine-2-carboxamides as RSK inhibitorsPHOENIX MOLECULAR DESIGNS·Filed 2017·Granted Sep 25, 2018·3 cites·17 claims
- 0381US9687466B2Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiformeDELMAR PHARMACEUTICALS INC·Filed 2014·Granted Jun 27, 2017·5 cites·42 claims
- 0476US2022193024A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2022·Application pending·0 cites
- 0575US10758530B2Carboxamide derivatives useful as rsk inhibitorsPHOENIX MOLECULAR DESIGNS·Filed 2017·Granted Sep 1, 2020·1 cites·19 claims
- 0675US2022142966A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2022·Application pending·0 cites
- 0772US11234955B2Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2019·Granted Feb 1, 2022·0 cites·7 claims
- 0871US10201521B2Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2013·Granted Feb 12, 2019·1 cites·6 claims
- 0965US2021186961A1Carboxamide derivatives useful as rsk inhibitorsPHOENIX MOLECULAR DESIGNS·Filed 2020·Application pending·0 cites
- 1058US2017266150A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multforme and medulloblastomaDELMAR PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1140US12378245B2Crystalline forms of an RSK inhibitorPHOENIX MOLECULAR DESIGNS·Filed 2020·Granted Aug 5, 2025·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →